AK Medical Holdings Limited provides consolidated earnings guidance for the year ended 31 December 2022. For the period, The company expects to record an increase in revenue by over 35% for the year ended 31 December 2022 as compared to the revenue for the year ended 31 December 2021; and the Board expects to record a significant increase in net profit attributable to Shareholders by over 100% for the year ended 31 December 2022 as compared to the net profit attributable to Shareholders for the year ended 31 December 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.81 HKD | +0.69% | +16.20% | -7.19% |
Apr. 22 | AK Medical Holdings' Surgical Robot Gets NMPA's Nod | MT |
Apr. 18 | Eric Wang to Retire as an Independent Non-Executive Director of AK Medical Holdings Limited | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.19% | 827M | |
+12.07% | 128B | |
-8.58% | 10.65B | |
+0.91% | 8.82B | |
+16.72% | 7.19B | |
+25.15% | 4.99B | |
+7.17% | 3.4B | |
-1.36% | 3.03B | |
-8.73% | 2.14B | |
-10.15% | 2B |
- Stock Market
- Equities
- 1789 Stock
- News AK Medical Holdings Limited
- AK Medical Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2022